Literature DB >> 3262644

Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line.

A Gougos1, M Letarte.   

Abstract

Staining of a variety of human tissue sections (lymph node, tonsil, spleen, thymus, kidney, lung, and liver) by the indirect immunoperoxidase method indicated that mAb 44G4, produced against a human pre-B leukemic cell line, was strongly reactive with vascular endothelium. All other cell types observed in these tissues were unreactive. Immunofluorescence staining of endothelial cells isolated from umbilical cord vein and grown in culture confirmed that mAb 44G4 recognized a surface membrane component of vascular endothelium. Granulocytes, monocytes, B and T lymphocytes, and T lymphocytes cultured in the presence of PHA for 72 h did not express the 44G4 Ag. mAb 44G4 reacted weakly with leukemic cells from 28 of 41 patients with non-T cell acute lymphocytic leukemia and 4 of 7 patients with acute myelocytic leukemia, whereas 8 of 10 cases of T cell acute lymphocytic leukemia were negative. Moderate reactivity with leukemic cell lines of pre-B and myelomonocytic origin was also observed. The level of 44G4 Ag on umbilical endothelial cells was three to five times that of leukemic cell lines and 25 times the average levels observed on leukemic cells isolated from patients. Immunoprecipitation of lysates prepared from surface-iodinated endothelial cells and the immunizing pre-B leukemic cell line revealed that the 44G4 Ag from both cell types was composed of two subunits of apparent m.w. 95,000 linked by disulfide bond(s). Comparison of the cellular localization and subunit structure of 44G4 to that of known Ag suggests that it represents a previously undescribed marker of endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262644

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

Review 1.  Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms.

Authors:  C L Shovlin; M Letarte
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

Review 2.  Endoglin-targeted cancer therapy.

Authors:  Ben K Seon; Akinao Haba; Fumihiko Matsuno; Norihiko Takahashi; Masanori Tsujie; Xinwei She; Naoko Harada; Shima Uneda; Tomoko Tsujie; Hirofumi Toi; Hilda Tsai; Yuro Haruta
Journal:  Curr Drug Deliv       Date:  2011-01       Impact factor: 2.565

3.  Proteolytic control of TGF-β co-receptor activity by BMP-1/tolloid-like proteases revealed by quantitative iTRAQ proteomics.

Authors:  Frédéric Delolme; Cyril Anastasi; Lindsay B Alcaraz; Valentin Mendoza; Sandrine Vadon-Le Goff; Maya Talantikite; Robin Capomaccio; Jimmy Mevaere; Laëtitia Fortin; Dominique Mazzocut; Odile Damour; Isabelle Zanella-Cléon; David J S Hulmes; Christopher M Overall; Ulrich Valcourt; Fernando Lopez-Casillas; Catherine Moali
Journal:  Cell Mol Life Sci       Date:  2014-09-27       Impact factor: 9.261

Review 4.  PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis.

Authors:  Sunyoung Park; Christine M Sorenson; Nader Sheibani
Journal:  Clin Sci (Lond)       Date:  2015-08       Impact factor: 6.124

Review 5.  Brain mesenchymal stem cells: The other stem cells of the brain?

Authors:  Florence Appaix; Marie-France Nissou; Boudewijn van der Sanden; Matthieu Dreyfus; François Berger; Jean-Paul Issartel; Didier Wion
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

6.  Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction.

Authors:  Franck Lebrin; Marie-José Goumans; Leon Jonker; Rita L C Carvalho; Gudrun Valdimarsdottir; Midory Thorikay; Christine Mummery; Helen M Arthur; Peter ten Dijke
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

7.  Primary angiosarcoma of the breast complicated by the syndrome of disseminated intravascular coagulation (DIC): Case report and literature review.

Authors:  Elena Alexandrova; Sonya Sergieva; Iglika Mihaylova; Antoaneta Zarkova
Journal:  Rep Pract Oncol Radiother       Date:  2013-12-08

8.  Tgf-Beta superfamily receptors-targets for antiangiogenic therapy?

Authors:  Jasmin Otten; Carsten Bokemeyer; Walter Fiedler
Journal:  J Oncol       Date:  2010-05-13       Impact factor: 4.375

Review 9.  Human microvessel endothelial cells: isolation, culture and characterization.

Authors:  P W Hewett; J C Murray
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-11       Impact factor: 2.416

Review 10.  Receptor-targeted anticancer therapy.

Authors:  Ben K Seon; Yuro Haruta; Fumihiko Matsuno; Akinao Haba; Norihiko Takahashi; Xinwei She; Naoko Harada; Shima Uneda; Masanori Tsujie; Tomoko Tsujie; Hirofumi Toi; Hilda Tsai
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.